IAIM
SRNE

International Assets Investment Management’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

International Assets Investment Management’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-14,600
Closed -$111K – 597
2021
Q3 		$111K Hold
14,600
– – 0.02% 479
2021
Q2 		$141K Sell
14,600
-4,898
-25% -$39K 0.03% 462
2021
Q1 		$155K Buy
19,498
+15,174
+351% +$160K 0.01% 578
2020
Q4 		$30K Buy
+4,324
New +$34.7K 0.01% 1025

Other funds holding SRNE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

International Assets Investment Management's SRNE Position: Q4 2021 in Review

International Assets Investment Management sold out of Sorrento Therapeutics, Inc. (SRNE) in Q4 2021, closing a stake of 14,600 shares — an estimated $111K sold.

International Assets Investment Management first reported a position in SRNE in Q4 2020 and held it in 4 quarters. The position peaked at $155K in Q1 2021. 234 funds tracked by Wall St. Rank hold SRNE as of Q4 2021.

  • International Assets Investment Management reported no remaining Sorrento Therapeutics, Inc. position as of Q4 2021 after selling out during the quarter.
  • International Assets Investment Management sold 14,600 Sorrento Therapeutics, Inc. shares in Q4 2021, an estimated $111K.
  • International Assets Investment Management first reported a position in Sorrento Therapeutics, Inc. in Q4 2020 and held it in 4 quarters.
  • International Assets Investment Management's Sorrento Therapeutics, Inc. position peaked at $155K in Q1 2021.
  • 234 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q4 2021.

Based on International Assets Investment Management's 13F filing for Q4 2021, filed 21 Jan 2022.